GLT-1 protein levels showed a regional decrease in epilepsy patients with hippocampal sclerosis and cortical dysplasia and in the intrahippocampal kainic acid (IHKA) model of epilepsy (Proper et al., 2002; Hubbard et al., 2016). This evidence concerns the gene SLC1A2 and epilepsy.